Home Tags Pfizer

Tag: Pfizer

Nivolumab + ipilimumab Shows Continued Survival in Patients with Metastatic Renal...

Peter Hofland, Ph.D -
The ceramic dragon fountain in the Parc Guell designed by Antoni Gaudi, Barcelona, Spain.

ESMO 2019: Seattle Genetics to Present Latest Study Data – Becomes...

Peter Hofland, Ph.D -
Human kidney cross section. Photo courtesy: 2019 Fotolia

Europe Adopts Pembrolizumab + Axitinib as First-Line Treatment for Advanced Renal...

Peter Hofland, Ph.D -

FDA Approves Pfizer’s Biosimilar rituximab-pvvr for Certain Cancers and Autoimmune Conditions

Peter Hofland, Ph.D -

Pfizer to Showcase Data from Innovative Science at 2019 Annual ASCO...

Peter Hofland, Ph.D -

Daiichi Sankyo to Colaborate with Merck KGaA and Pfizer in Development...

Peter Hofland, Ph.D -

FDA Accepts New Drug Application for Pfizer?s Third-Generation ALK Inhibitor Lorlatinib

Sonia Portillo -
Human kidney cross section. Photo courtesy: 2019 Fotolia

New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer

Peter Hofland, Ph.D -
Attendees during American Society of Clinical Oncology (ASCO) Annual Meeting. Courtesy: ? ASCO/Scott Morgan

Dacomitinib may Offer New Treatment Option for Patients with EGFR-Positive Lung...

Peter Hofland, Ph.D -

Pfizer Discontinues Clinical Trial with Inotuzumab Ozogamicin in Relapsed or Refractory...

Editorial Team -

LATEST

© 2020 Sunvalley Communication, LLC. All Rights Reserved.